Browse Technologies by  

UPN Ref Application Title and Description
196 Particles design
SCF processes are developed for increasing bio-availability of poorly soluble molecules, designing sustained -release formulations and preparing drug delivery.
View Technology
47 Evaluation of digestibility of pharmaceuticals
To assess bioavailability, bioconversion and mode of action of single substances and/or combinatory effects of complex mixtures after total digestion or at each step. Explanation of unwanted side-reactions which occurred in individuals during clinical studies.
View Technology
35 Food-drug effect evaluation
Assessment of the effect of food on the lumenal availability and absorption of pharmaceutical products.
View Technology
35 Dose-dumping assessment
Testing to predict likelihood of dosage form failured that could lead to sudden release of the active.
View Technology
35 Alcohol interaction quantification
Assessment of the effect of alcohol on the integrity and drug release performance of opioid based products.
View Technology
35 Gastro-retentive dosage forms evaluation
Evaluation of dosage forms designed to remain robust within the stomach environment to facilitate controlled delivery of active to the small intestine.
View Technology
35 Metabolism and stability assessment
Assessment of the metabolic and hydrolytic stability of oral pharmaceutical products.
View Technology
35 Biorelevant testing of pharmaceuticals
Evaluation of dissolution of poorly soluble drugs.
View Technology